All Stories

  1. Artificial intelligence automation of urine culture reading with BD Kiestra Urine Culture Application: measurement of performance and potential efficiency gains
  2. Australian contribution to the history of amoebic meningitis and encephalitis
  3. Genomic interrogation of invasive group A Streptococcus (iGAS) epidemiology and COVID-19 impacts in Victoria, Australia: a 6-year retrospective study
  4. Burkholderia cenocepacia outbreak linked to taps in a neonatal intensive care unit
  5. Is neutrophil to lymphocyte ratio an accurate predictor of neonatal sepsis in premature infants?
  6. Identifying Gaps in the International Consensus Case Definitions for Invasive Aspergillosis: A Review of Clinical Cases Not Meeting These Definitions
  7. Use of echinocandin outpatient parenteral antimicrobial therapy for the treatment of infection caused by Candida spp.: utilization, outcomes and impact of a change to weekly dosing
  8. HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD)
  9. ATAGI Targeted Review 2023: Vaccination for prevention of influenza in Australia
  10. Treatment‐resistant tinea caused by Trichophyton indotineae in Australia
  11. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
  12. Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia
  13. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial
  14. Pathogenomic analysis and characterization of Pasteurella multocida strains recovered from human infections
  15. Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future
  16. Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)
  17. Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
  18. Utility of Proximal Bone Cultures in Diabetes-related Foot Infections
  19. Comparison of contemporary invasive and non-invasive Streptococcus pneumoniae isolates reveals new insights into circulating anti-microbial resistance determinants
  20. Nocardia species distribution and antimicrobial susceptibility within Australia
  21. Invasive aspergillosis in adult patients in Australia and New Zealand: 2017–2020
  22. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
  23. Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand
  24. Clostridioides difficileInfection: Clinical Practice and Health Outcomes in 6 Large Tertiary Hospitals in Eastern Australia
  25. A rise in invasive and non‐invasive group A streptococcal disease case numbers in Melbourne in late 2022
  26. A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses
  27. Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000–2012)
  28. Long term antibiotic prescribing in the community: 6 years of Australian national data
  29. Impact of Kiestra total laboratory automation workflow on job satisfaction, education and quality: a staff survey
  30. New diagnosis of HIV with Cryptococcus neoformans infection presenting as a pleural syndrome
  31. Trichomoniasis among men presenting to a sexual health clinic in Melbourne, Australia
  32. Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis
  33. Acute Tubular Necrosis and Thrombocytopenia Associated With Rifampin Use: Case Report and Review
  34. Outcomes in Medicare‐ineligible people living with human immunodeficiency virus in a large healthcare network in Melbourne 2004–2019
  35. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network FluCAN
  36. Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines
  37. Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data
  38. Genomic characterisation of CC398 MRSA causing severe disease in Australia
  39. Corynebacterium macginleyi in the era of MALDI-TOF MS: epidemiology, susceptibility patterns and prevalence of co-infection
  40. Long-Term Outcomes in Patients on Life-Long Antibiotics: A Five-Year Cohort Study
  41. Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV
  42. Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)
  43. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19
  44. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)
  45. Coronavirus testing in women attending antenatal care
  46. Molecular characterization of fosfomycin-resistant Escherichia coli urinary tract infection isolates from Australia
  47. Moving beyond “Red Man Syndrome”
  48. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015–18
  49. Infective Endocarditis in Patients on Chronic Hemodialysis
  50. Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient
  51. Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment
  52. Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
  53. Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis
  54. COVID‐19 in Australia: our national response to the first cases of SARS‐CoV‐2 infection during the early biocontainment phase
  55. Etymologia: Buruli Ulcer
  56. Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia
  57. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018
  58. Case Report: Japanese Encephalitis Associated with Chorioretinitis after Short-Term Travel to Bali, Indonesia
  59. Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia
  60. Viral Genomics to Inform Infection-control Response in Occupational Coronavirus Disease 2019 (COVID-19) Transmission
  61. RE: “EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS”
  62. Rapid Gel Card Agglutination Assays for Serological Analysis Following SARS-CoV-2 Infection in Humans
  63. Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay
  64. Isolation and rapid sharing of the 2019 novel coronavirus ( SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia
  65. The burden of infective endocarditis in an Australian cohort of people who inject drugs
  66. Intermittent negative blood cultures in Staphylococcus aureus bacteremia; A retrospective study of 1071 episodes
  67. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN)
  68. Should we routinely test for Mycoplasma genitalium when testing for other sexually transmitted infections?
  69. Surveillance of life-long antibiotics—A cross-sectional cohort study assessing patient attitudes and understanding of long-term antibiotic consumption
  70. HIV presenting as AIDS in previously undiagnosed tourists in a low-prevalence setting
  71. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?
  72. Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN)
  73. Genomic interrogation of the burden and transmission of multidrug-resistant pathogens within and across hospital networks
  74. Management of gonorrhoea in a hospital network: are we following best practice?
  75. Response to letter to editor regarding Lin et al ‘Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?’
  76. Anti-Helicobacter pylori activity of ethoxzolamide
  77. Identification and diversity of Actinomyces species in a clinical microbiology laboratory in the MALDI-TOF MS era
  78. Prevalence of HIV indicator conditions in late presenting patients with HIV: a missed opportunity for diagnosis?
  79. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
  80. Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
  81. Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration
  82. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols
  83. Foreign tick smuggling rickettsia evades Australian border control
  84. Respiratory virus detection and co-infection in children and adults in a large Australian hospital in 2009-2015
  85. Life-long antimicrobial therapy: where is the evidence?
  86. C-reactive protein and immature-to-total neutrophil ratio have no utility in guiding lumbar puncture in suspected neonatal sepsis
  87. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia
  88. Underdiagnosis of Chlamydia trachomatis and Chlamydia psittaci revealed by introduction of respiratory multiplex PCR assay with Chlamydiaceae family primers
  89. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27
  90. Myocarditis Caused by Human Parechovirus in Adult
  91. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the Internati...
  92. Herpes simplex virus-2 transmission following solid organ transplantation: Donor-derived infection and transplantation from prior organ recipients
  93. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
  94. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study
  95. Teicoplanin non-susceptible coagulase-negative staphylococci in a large Australian healthcare network: Implications for treatment with vancomycin
  96. Management of dengue in Australian travellers: a retrospective multicentre analysis
  97. Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza
  98. The impact of changes in HIV management guidelines on time to treatment initiation in Australia
  99. Changing epidemiology of candidaemia in Australia
  100. Integrase-resistant HIV in an antiretroviral-naive patient in Australia
  101. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian Healthcare Network
  102. Polyclonal emergence ofvanAvancomycin-resistantEnterococcus faeciumin Australia
  103. Changing epidemiology of candidaemia in Australia
  104. Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance...
  105. Bacteroides pyogenes causing serious human wound infection from animal bites
  106. Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children
  107. Improved standardization and potential for shortened time to results with BD Kiestra™ total laboratory automation of early urine cultures: A prospective comparison with manual processing
  108. Cryptococcemia in primary HIV infection
  109. Increasing tolerance of hospital Enterococcus faecium to hand-wash alcohols
  110. Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis
  111. Australasian Society of Infectious Diseases updated guidelines for the management ofClostridium difficileinfection in adults and children in Australia and New Zealand
  112. Different faces of Nocardia infection in renal transplant recipients
  113. Mucormycosis in Australia: contemporary epidemiology and outcomes
  114. Combination Therapy Did Not Reduce 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia (SAB)
  115. Prediction Model to Identify Patients at Risk of 30-Day Treatment Failure in Patients With Staphylococcus aureus Bacteremia
  116. Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014
  117. Low rates of endocarditis in healthcare-associated Staphylococcus aureus bacteremia suggest that echocardiography might not always be required
  118. Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service
  119. Disseminated Enteroviral Infection Associated with Obinutuzumab
  120. A history of infection with varicella is strongly predictive of the presence of varicella-zoster virus antibodies in a heterogenous Australian HIV cohort
  121. Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)
  122. Acute HIV infection presenting as erythema multiforme in a 45-year-old heterosexual man
  123. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia
  124. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile , 2013–14
  125. Human Wound Infection with Mannheimia glucosida following Lamb Bite
  126. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality
  127. Correction: Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
  128. Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1 gene in Australia
  129. Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012
  130. Diagnosis and Management of Clostridium difficile Infection
  131. Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy
  132. Vancomycin vintage: my favourite DRESS
  133. Association Between Surgical Indications, Operative Risk, and Clinical Outcome in Infective Endocarditis
  134. Mycobacterium haemophilumbone and joint infection in HIV/AIDS: case report and literature review
  135. Who really knows their patients' penicillin adverse drug reaction status? A cross-sectional survey
  136. One-year outcome following biological or mechanical valve replacement for infective endocarditis
  137. Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure
  138. Clinical and Microbiological Characteristics of Eggerthella lenta Bacteremia
  139. Acanthamoeba Encephalitis: Isolation of Genotype T1 in Mycobacterial Liquid Culture Medium
  140. Comparing the identification of Clostridium spp. by two Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry platforms to 16S rRNA PCR sequencing as a reference standard: A detailed analysis of age of culture and sam...
  141. HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD)
  142. Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study
  143. Rapid Time to Results and High Sensitivity of the CarbaNP Test on Early Cultures
  144. Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates
  145. Emergence of a Ribotype 244 Strain of Clostridium difficile Associated With Severe Disease and Related to the Epidemic Ribotype 027 Strain
  146. Eggerthella lenta Bacteremia Complicated by Spondylodiscitis, Psoas Abscess, and Meningitis
  147. Comparing the identification of clostridium SPP. from blood culture using phenotypic, molecular, and two matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry methods: a detailed analysis including the impact of cultu...
  148. Novel use of toxigenic gene analysis for the identification of clostridium species
  149. Vancomycin-resistant enterococci colonization does not increase mortality in end-stage kidney failure: a case–control study
  150. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia
  151. Hampered by historical paradigms - echinocandins and the treatment ofCandidaendocarditis
  152. Streptococcus pyogenes aortic aneurysm infection: forgotten but not gone
  153. Exacerbation phenotyping in chronic obstructive pulmonary disease
  154. Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010–11 Seasons: A Test-negative Observational Study
  155. Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services
  156. Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii
  157. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
  158. “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks
  159. Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
  160. Influence of the Timing of Cardiac Surgery on the Outcome of Patients With Infective Endocarditis and Stroke
  161. Successful use of eltrombopag without splenectomy in refractory HIV-related immune reconstitution thrombocytopenia
  162. Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death
  163. New HIV diagnosis after occupational exposure screening: the importance of reporting needlestick injuries
  164. Prevalence of antimicrobial-resistant organisms in residential aged care facilities
  165. Contamination of renal patients hospital chart covers with vancomycin resistant enterococci: Handle!with care
  166. The Dominant Australian Community-Acquired Methicillin-Resistant Staphylococcus aureus Clone ST93-IV [2B] Is Highly Virulent and Genetically Distinct
  167. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study
  168. Rat bite fever as a presenting illness in a patient with AIDS
  169. Methicillin-Susceptible Staphylococcus aureus Endocarditis Isolates Are Associated With Clonal Complex 30 Genotype and a Distinct Repertoire of Enterotoxins and Adhesins
  170. Clostridium difficile laboratory testing in Australia and New Zealand: national survey results and Australasian Society for Infectious Diseases recommendations for best practice
  171. Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
  172. Curtobacterium flaccumfaciens Septic Arthritis following Puncture with a Coxspur Hawthorn Thorn
  173. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
  174. Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemia
  175. Novel Use of Tryptose Sulfite Cycloserine Egg Yolk Agar for Isolation of Clostridium perfringens during an Outbreak of Necrotizing Enterocolitis in a Neonatal Unit
  176. Autoimmune haemolytic anaemia: an unusual presentation of HIV seroconversion disease
  177. Neurocysticercosis Causing Sudden Death
  178. MELTING MUSCLES
  179. Heterogeneous Vancomycin‐Intermediate Susceptibility Phenotype in Bloodstream Methicillin‐Resistant Staphylococcus aureus Isolates from an International Cohort of Patients with Infective Endocarditis: Prevalence, Genotype, and Clinical Significance
  180. Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy
  181. Determinants of mortality in non-neutropenic ICU patients with candidaemia
  182. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection
  183. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management
  184. Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience
  185. Primary psoas muscle abscess in pregnancy
  186. SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia
  187. Report of oral clarithromycin desensitization
  188. Phylogenetic Analysis of Viridans Group Streptococci Causing Endocarditis
  189. The Etiology of Community‐Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
  190. Genotypic Diversity of Coagulase-Negative Staphylococci Causing Endocarditis: a Global Perspective
  191. Constructing clinical indicators for multiresistant organisms. Where do we begin?
  192. Investigation of an outbreak of Serratia marcescens in a neonatal unit via a case-control study and molecular typing
  193. Molecular Typing of AustralianScedosporiumIsolates Showing Genetic Variability and NumerousS. aurantiacum
  194. Disinfection of Burkholderia cepacia complex from non-touch taps in a neonatal nursery
  195. Unrecognised vitamin D deficiency: low concentrations in African migrants with HIV in Australia
  196. What's hanging around your neck? Pathogenic bacteria on identity badges and lanyards
  197. Non-HACEK Gram-Negative Bacillus Endocarditis
  198. A longitudinal study of Acinetobacter in three Australian hospitals
  199. Corynebacterium kutscheri Infection of Skin and Soft Tissue following Rat Bite
  200. Risk factors for peritoneal dialysis-related peritonitis: Can we reduce the incidence and improve patient selection?
  201. Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens
  202. Acute pancreatitis caused by tipranavir/ritonavir-induced hypertriglyceridaemia
  203. Rat-bite fever septic arthritis: illustrative case and literature review
  204. Active Surveillance of Candidemia, Australia
  205. Duration of In Vivo Antimicrobial Activity of Antibiotic-impregnated Cerebrospinal Fluid Catheters
  206. Infectious complications of traditional Samoan tattooing
  207. The microbiology and outcome of sepsis in Victoria, Australia
  208. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database
  209. Eosinophilic folliculitis
  210. Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient
  211. Fatal Case of Toxic Shock-Like Syndrome Due to Group C Streptococcus Associated with Superantigen Exotoxin
  212. Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital
  213. Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
  214. Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis
  215. Management of Aspergillus Osteomyelitis: Report of Failure of Liposomal Amphotericin B and Response to Voriconazole in an Immunocompetent Host and Literature Review
  216. Bacteraemia due to Stenotrophomonas maltophilia: An Analysis of 45 Episodes
  217. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis
  218. FatalLegionella longbeachae infection following heart transplantation
  219. Polymicrobial septicaemia with Pseudomonas aeruginosa and Streptococcus pyogenes following traditional tattooing
  220. Acute hepatitis associated withCampylobacter jejuni bacteraemia
  221. The 1-month outcome of patients with a low probability Technegas ventilation/perfusion lung scan